Cyc-H-LRRFSTMPFMFCNINNVCNF-NH2

Ref. 3D-PP45067

Informations sur le produit

• Nom: Cyc-H-LRRFSTMPFMFCNINNVCNF-NH2
• Synonymes: Cyc-NH2-Leu-Arg-Arg-Phe-Ser-Thr-Met-Pro-Phe-Met-Phe-Cys-Asn-Ile-Asn-Asn-Val-Cys-Asn-Phe-amide

Description

Peptide Cyc-H-LRRFSTMPFMFCNINNVCNF-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Cyc-H-LRRFSTMPFMFCNINNVCNF-NH2 include the following: Extracellular matrix glycoprotein-derived synthetic peptides differentially modulate glioma and sarcoma cell migration N Brösicke, M Sallouh, LM Prior, A Job - Cellular and molecular , 2015 - Springerhttps://link.springer.com/article/10.1007/s10571-015-0170-1 Peptides derived from type IV collagen, CXC chemokines, and thrombospondin-1 domain-containing proteins inhibit neovascularization and suppress tumor growth in JE Koskimaki, ED Karagiannis , EV Rosca , F Vesuna - Neoplasia, 2009 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1476558609800973 Pentastatin-1, a collagen IV derived 20-mer peptide, suppresses tumor growth in a small cell lung cancer xenograft model JE Koskimaki, ED Karagiannis , BC Tang , H Hammers - BMC cancer, 2010 - Springerhttps://link.springer.com/article/10.1186/1471-2407-10-29 Synergy between a collagen IV mimetic peptide and a somatotropin-domain derived peptide as angiogenesis and lymphangiogenesis inhibitors JE Koskimaki, E Lee , W Chen , CG Rivera , EV Rosca - Angiogenesis, 2013 - Springerhttps://link.springer.com/article/10.1007/s10456-012-9308-7 Structure-Activity Relationship Study of Collagen-Derived Anti-Angiogenic Biomimetic Peptides EV Rosca , JE Koskimaki, NB Pandey - Chemical biology & , 2012 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1747-0285.2012.01376.x Collagen IV and CXC chemokine-derived antiangiogenic peptides suppress glioma xenograft growth EV Rosca , B Lal , JE Koskimaki, AS Popel - Anti-cancer , 2012 - journals.lww.comhttps://journals.lww.com/anti-cancerdrugs/FullText/2012/08000/Collagen_IV_and_CXC_chemokine_derived.5.aspx

• Marque: Biosynth